Back to Search Start Over

De novo biosynthesis of 2'-fucosyllactose by bioengineered Corynebacterium glutamicum.

Authors :
Lee YG
Jo HY
Lee DH
Yoon JW
Song YH
Kweon DH
Kim KH
Park YC
Seo JH
Source :
Biotechnology journal [Biotechnol J] 2024 Jan; Vol. 19 (1), pp. e2300461. Date of Electronic Publication: 2023 Nov 30.
Publication Year :
2024

Abstract

2'-Fucosyllactose (2'-FL) which is well-known human milk oligosaccharide was biotechnologically synthesized using engineered Corynebacterium glutamicum, a GRAS microbial workhorse. By construction of the complete de novo pathway for GDP-L-fucose supply and heterologous expression of Escherichia coli lactose permease and Helicobacter pylori α-1,2-fucosyltransferase, bioengineered C. glutamicum BCGW_TL successfully biosynthesized 0.25 g L <superscript>-1</superscript> 2'-FL from glucose. The additional genetic perturbations including the expression of a putative 2'-FL exporter and disruption of the chromosomal pfkA gene allowed C. glutamicum BCGW_cTTLEΔP to produce 2.5 g L <superscript>-1</superscript> 2'-FL batchwise. Finally, optimized fed-batch cultivation of the BCGW_cTTLEΔP using glucose, fructose, and lactose resulted in 21.5 g L <superscript>-1</superscript> 2'-FL production with a productivity of 0.12 g L <superscript>-1</superscript> •h, which were more than 3.3 times higher value relative to the batch culture of the BCGW_TL. Conclusively, it would be a groundwork to adopt C. glutamicum for biotechnological production of other food additives including human milk oligosaccharides.<br /> (© 2023 Wiley-VCH GmbH.)

Details

Language :
English
ISSN :
1860-7314
Volume :
19
Issue :
1
Database :
MEDLINE
Journal :
Biotechnology journal
Publication Type :
Academic Journal
Accession number :
37968827
Full Text :
https://doi.org/10.1002/biot.202300461